SCHEMBL6920472

SCHEMBL6920472

Cc1ccc2c(c1)c1c(OCCC(N)=O)cccc1n2Cc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 20/20 0.56
PLA2G1B P04054 2/20 0.48
PLA2G10 O15496 1/20 0.48
PLA2G5 P39877 1/20 0.48
PLA2G2E Q9NZK7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6923328 0.86 PLA2G2A (0.45) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL6926722 0.82 HTR6 (0.48) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL6925514 0.81 MAPK1 (0.48) PLA2G2A
SCHEMBL6920470 0.81 HTR6 (0.52) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL6923666 0.79 KMT2A (0.44) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL6923678 0.77 PLA2G2A (0.50) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E
SCHEMBL6923659 0.75 KMT2A (0.51) PLA2G2A
SCHEMBL6925585 0.74 MEN1 (0.47) PLA2G2A
SCHEMBL6924402 0.74 HTR6 (0.49) PLA2G2APLA2G1B
SCHEMBL6924330 0.74 P2RX4 (0.52) PLA2G2APLA2G1BPLA2G10PLA2G5PLA2G2E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed